News round-up for 14-18 April by DDW Senior Digital Content Editor Diana Spencer.

In a week of financial uncertainty for the industry, our round-up focuses on the power of partnership to accelerate drug discovery, from the prevention of respiratory infections, to mapping gene activity in inflammatory bowel disease.

The top stories:

Partners develop non-invasive mRNA vaccines

Ethris and Lonza have announced a collaboration to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates.

Read more…

Vaccine centre hosts study of antiviral host defence enhancer

ENA Respiratory and the University of Maryland have announced plans to partner on a Phase II study of INNA-051 for the prevention of illness due to viral respiratory infections.

Read more…

Collaboration award for Dundee PROTAC drug discovery project

A research team at the University of Dundee have been recognised for their work with industry partner, Boehringer Ingelheim, with the Biochemical Society’s 2026 Industry and Academic Collaboration Award.

Read more…

RNA mapping project focuses on inflammatory bowel disease

Scientists at the Wellcome Sanger Institute in collaboration with Pacific Biosciences (PacBio) have launched a new initiative to map how gene activity shapes the immune system.

Read more…

M42 partners with Juvenescence on longevity drug discovery

Global health company M42 has announced a strategic investment and partnership with longevity biotech Juvenescence.

Read more…